Remdesivir and Dexamethasone for the Treatment of COVID-19 - a podcast by JAMA Network

Both remdesivir and dexamethasone have been promoted as effective treatments for COVID-19. JAMA Deputy Editor Greg Curfman, MD, and Professor Rachel Sachs, JD, from the Washington University School of Law discuss the science and health policy aspects of these COVID-19 treatments.

Related Article(s):

Missed Opportunities on Emergency Remdesivir Use

Further episodes of Coronavirus (COVID-19) Q&A

Further podcasts by JAMA Network

Website of JAMA Network